Enzo Biochem, Inc. (LON:0IHV)

Market Cap	21.67M
Revenue (ttm)	23.41M
Net Income (ttm)	-17.15M
Shares Out	n/a
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Nov 15, 2024

Volume	3,000
Average Volume	3,248
Open	0.4850
Previous Close	n/a
Day's Range	0.4601 - 0.4850
52-Week Range	0.5556 - 1.1396
Beta	0.96
RSI	57.10
Earnings Date	Jun 13, 2025

About Enzo Biochem

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, ge...

• Industry: Laboratory Analytical Instruments
• Founded: 1976
• Employees: 136
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0IHV

Financial Performance

Financial numbers in USD